Number of the records: 1  

faktor nekrotizujúci nádory, alfa

  1. SYSd014409
    LBL
      
    00000cx--j22000003--45--
    005
      
    20240119201241.2
    100
      
    $a 19920508csloy0103----ba0
    152
      
    $b mesh
    250
      
    $a faktor nekrotizujúci nádory, alfa $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $8 slo
    300
    1-
    $a 2005(1988) $8 eng
    300
    1-
    $a Endotoxins (1975-1987) $8 eng
    300
    1-
    $a Glycoproteins (1975-1987) $8 eng
    300
    1-
    $a Necrosis (1975-1987) $8 eng
    330
    1-
    $a Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. $8 eng
    450
      
    $a Cachectin $5 e $8 eng
    450
      
    $a TNF-alpha $5 e $8 eng
    450
      
    $a Tumor Necrosis Factor Ligand Superfamily Member 2 $5 e $8 eng
    450
      
    $a kachektín $5 e $8 slo
    450
      
    $a TNF-alfa $5 e $8 slo
    450
      
    $a faktor nekrotizujúci tumory, alfa $5 e $8 slo
    450
      
    $a tumor nekrotizujúci faktor alfa $5 e $8 slo
    450
      
    $a superrodina ligandov faktora nekrotizujúceho nádory, člen 2 $5 e $8 slo
    550
      
    $3 sllk_un_auth*d000068582 $Y Certolizumab Pegol $5 B $a certolizumab pegol
    550
      
    $3 sllk_un_auth*d000068879 $Y Adalimumab $5 B $a adalimumab
    550
      
    $3 sllk_un_auth*d000069285 $Y Infliximab $5 B $a infliximab
    550
      
    $3 sllk_un_auth*d009336 $Y Necrosis $5 B $a nekróza
    550
      
    $3 sllk_un_auth*d000068879 $Y Adalimumab $5 F $a adalimumab
    550
      
    $3 sllk_un_auth*d000068582 $Y Certolizumab Pegol $5 F $a certolizumab pegol
    550
      
    $3 sllk_un_auth*d000069285 $Y Infliximab $5 F $a infliximab
    550
      
    $3 sllk_un_auth*d015275 $Y Tumor Lysis Syndrome $5 B $a syndróm lýzy nádoru
    686
      
    $a D09.400.430.965
    686
      
    $a D12.644.276.374.500.800
    686
      
    $a D12.644.276.374.750.626
    686
      
    $a D12.776.124.900
    686
      
    $a D12.776.395.930
    686
      
    $a D12.776.467.374.500.800
    686
      
    $a D12.776.467.374.750.626
    686
      
    $a D23.529.374.500.800
    686
      
    $a D23.529.374.750.626
    750
      
    $a Tumor Necrosis Factor-alpha $8 eng
    801
    -0
    $a US $b DNLM $c 19920508
    801
    -2
    $a SK $b BA006 $c 20070413
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.